GlassScriptPhysician profile
Ariel M Kaufman
NPI 1275955981
$9,754.06
in general payments reported to CMS, 2019-2025
43 companies · $1,676 in 2025
The $1,676 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,644 · 2020: $1,543 · 2021: $1,129 · 2022: $1,604 · 2023: $970 · 2024: $1,188 · 2025: $1,676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,527 · Education: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,526.51 |
| Education | $307.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,791.13 | 2019-2025 | Erleada, Akeega |
| Boston Scientific Corporation | $1,324.33 | 2019-2025 | General - Erectile Dysfunction, Ams 700, Compliance Endokit |
| Astellas Pharma US INC | $1,313.71 | 2019-2023 | Myrbetriq, Xtandi |
| Pfizer INC. | $791.64 | 2019-2025 | |
| Olympus Corporation of The Americas | $635.79 | 2020 | |
| Abbvie INC. | $562.75 | 2019-2025 | |
| Tolmar Pharmaceuticals, INC. | $414.80 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $255.71 | 2022-2025 | |
| Coloplast Corp | $216.30 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $204.53 | 2019-2022 | |
| Accord Healthcare, INC. | $190.61 | 2025 | |
| Procept Biorobotics Corporation | $177.92 | 2021-2025 | |
| Verity Pharmaceuticals INC. | $168.85 | 2024-2025 | Tlando, Trelstar |
| Telix Pharmaceuticals | $153.52 | 2022-2025 | Illuccix |
| Merck Sharp & Dohme LLC | $151.56 | 2020-2023 | Keytruda, Lynparza |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ariel Kaufman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.